Duke Energy Corp vs DexCom, Inc. — how do they compare? Duke Energy Corp trades at $123.7 (market cap $96.05B), while DexCom, Inc. trades at $90.8 (market cap $33.79B). The key difference: Duke Energy Corp is far larger — about 2.8× DexCom, Inc.'s market cap, and Duke Energy Corp pays a 3.52% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DUK | DXCM | |
|---|---|---|
Market Cap | $96.05B | $33.79B |
Sector | Utilities | Health |
52-Week High | $133.46 | $89.53 |
52-Week Low | $113.99 | $54.84 |
Enterprise Value | $188.56B | $33.24B |
Dividend Yield | 3.52% | — |
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $123.23, up 1.68% with a bearish technical signal despite strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $1.43 exceeding expectations, supported by growing revenue and healthy profit margins. Recent news highlights operational challenges from storms affecting customers but also strategic initiatives including a $35 million equity units offering and data center growth opportunities.
The outlook remains stable with analyst consensus pointing to upside potential (target $136.17) and no sell ratings. Key risks include regulatory scrutiny and capital expenditure pressures, but the company's dividend reliability and infrastructure investments provide long-term stability. The stock presents a balanced opportunity for income-focused investors amid current technical weakness.
DXCM trades at $91.00, up 3.82% today and near its 52-week high, with bullish technical signals from moving averages and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $0.70 versus $0.61 expected, driven by 13% revenue growth and margin expansion. The company raised full-year 2026 guidance, reflecting robust demand for continuous glucose monitors.
The outlook is positive due to sustained revenue growth, profitability improvements, and analyst consensus favoring buys. Risks include competitive pressures and potential regulatory scrutiny, but institutional ownership trends and earnings momentum support a constructive view for investors seeking exposure to medical technology.
Trailing returns across standard periods
Latest headlines on both assets
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →